Cryo Cell International (CCEL) Gains from Sales and Divestitures (2012 - 2018)

Cryo Cell International has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $50550.0 for Q3 2018.

• In Q3 2018, Gains from Sales and Divestitures rose 47.06% year-over-year to $50550.0; the TTM figure through Aug 2018 stood at $50550.0 (up 47.06% YoY), while the FY2017 annual figure was $83238.0, down 31.95% from the prior year.
• Gains from Sales and Divestitures grew to $50550.0 in Q3 2018, from $41797.0 in the prior quarter.
• Over the last five years, Gains from Sales and Divestitures for CCEL reached as high as $122326.0 in Q4 2016 and fell as low as $5625.0 in Q1 2016.
• The 5-year median for Gains from Sales and Divestitures is $34580.0 (2015), against an average of $44298.3.
• Annual changes were most pronounced in 2016 — Gains from Sales and Divestitures surged 261.86% — and 2017, when it plunged 63.76%.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $75409.0 in 2014, then sank by 54.14% to $34580.0 in 2015, then jumped by 253.75% to $122326.0 in 2016, then slumped by 31.95% to $83238.0 in 2017, then tumbled by 39.27% to $50550.0 in 2018.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $50550.0, $41797.0, and $18957.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.